Xu et al. [26] showed that withaferin A blocked TGF-β-dependent Smad2 phosphorylation and expression of other TGF-β-related proteins in human endometrial cancer cells, suggesting that withaferin A inhibits the proliferation of human endometrial carcinoma via TGF-β signal regulation. The gene discussed is TGFB1; the disease is endometrial cancer.